NotesFAQContact Us
Collection
Advanced
Search Tips
Showing all 6 results Save | Export
Peer reviewed Peer reviewed
Direct linkDirect link
Silja H. Overgaard; Caroline M. Moos; John P. A. Ioannidis; George Luta; Johannes I. Berg; Sabrina M. Nielsen; Vibeke Andersen; Robin Christensen – Research Synthesis Methods, 2024
The objective of this meta-epidemiological study was to explore the impact of attrition rates on treatment effect estimates in randomised trials of chronic inflammatory diseases (CID) treated with biological and targeted synthetic disease-modifying drugs. We sampled trials from Cochrane reviews. Attrition rates and primary endpoint results were…
Descriptors: Epidemiology, Attrition (Research Studies), Chronic Illness, Program Effectiveness
Peer reviewed Peer reviewed
Direct linkDirect link
Jennifer L. Proper; Haitao Chu; Purvi Prajapati; Michael D. Sonksen; Thomas A. Murray – Research Synthesis Methods, 2024
Drug repurposing refers to the process of discovering new therapeutic uses for existing medicines. Compared to traditional drug discovery, drug repurposing is attractive for its speed, cost, and reduced risk of failure. However, existing approaches for drug repurposing involve complex, computationally-intensive analytical methods that are not…
Descriptors: Network Analysis, Meta Analysis, Prediction, Drug Therapy
Peer reviewed Peer reviewed
Direct linkDirect link
Held, Leonhard; Matthews, Robert; Ott, Manuela; Pawel, Samuel – Research Synthesis Methods, 2022
It is now widely accepted that the standard inferential toolkit used by the scientific research community--null-hypothesis significance testing (NHST)--is not fit for purpose. Yet despite the threat posed to the scientific enterprise, there is no agreement concerning alternative approaches for evidence assessment. This lack of consensus reflects…
Descriptors: Bayesian Statistics, Statistical Inference, Hypothesis Testing, Credibility
Peer reviewed Peer reviewed
Direct linkDirect link
Günhan, Burak Kürsad; Röver, Christian; Friede, Tim – Research Synthesis Methods, 2020
Meta-analyses of clinical trials targeting rare events face particular challenges when the data lack adequate numbers of events for all treatment arms. Especially when the number of studies is low, standard random-effects meta-analysis methods can lead to serious distortions because of such data sparsity. To overcome this, we suggest the use of…
Descriptors: Meta Analysis, Medical Research, Drug Therapy, Bayesian Statistics
Peer reviewed Peer reviewed
Direct linkDirect link
Donegan, Sarah; Welton, Nicky J.; Tudur Smith, Catrin; D'Alessandro, Umberto; Dias, Sofia – Research Synthesis Methods, 2017
Background: Many reviews aim to compare numerous treatments and report results stratified by subgroups (eg, by disease severity). In such cases, a network meta-analysis model including treatment by covariate interactions can estimate the relative effects of all treatment pairings for each subgroup of patients. Two key assumptions underlie such…
Descriptors: Network Analysis, Meta Analysis, Outcomes of Treatment, Comparative Analysis
Peer reviewed Peer reviewed
Direct linkDirect link
Leahy, Joy; O'Leary, Aisling; Afdhal, Nezam; Gray, Emma; Milligan, Scott; Wehmeyer, Malte H.; Walsh, Cathal – Research Synthesis Methods, 2018
The use of individual patient data (IPD) in network meta-analysis (NMA) is becoming increasingly popular. However, as most studies do not report IPD, most NMAs are performed using aggregate data for at least some, if not all, of the studies. We investigate the benefits of including varying proportions of IPD studies in an NMA. Several models have…
Descriptors: Patients, Medical Research, Meta Analysis, Network Analysis